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Summary A number of rare human inherited syndromes are associated with apparent defects in DNA repair
and a greatly increased frequency of cancer. Cell lines derived from such individuals phenotypically resemble
certain bacterial mutant strains that have increased sensitivity to radiation or chemical agents and well
characterised repair defects. This analogy provides leads for unravelling the molecular alterations in such
cancer-prone human cells. The inducibility of DNA repair enzymes is also reviewed. Exposure of bacteria to
alkylating agents, or oxygen radicals, causes the overproduction of several novel and interesting repair
activities, and the induced bacteria provide an abundant source of these proteins for purification and
biological characterisation. Enzymes with the same defined specificities are often present in human cells,
presumably serving the same functions as in microorganisms, but these activities are only constitutively
expressed at low levels.
The major DNA repair processes appear to be universally
distributed among living cells. They probably evolved at a
very early stage to counteract DNA damage caused by heat-
induced hydrolysis, ultraviolet light, ionising radiation, and
certain reactive chemicals. The same processes continue to
serve these functions in human cells, and provide important
protection against many environmental mutagens and
carcinogens. Since the correction pathways tend to minimise
the consequences of radiation and group-specific agents
acting on DNA, however, they also have the unwanted side
effect of opposing the action of anticancer drugs and
radiation therapy. For this reason, it is of considerable
interest to elucidate in molecular detail the different
individual steps in various specific repair pathways, in order
to develop targeted inhibitors of DNA repair.
Similar repair functions exist in man and in genetically
well characterised microorganisms such as E. coli and yeast.
The stringent characterisation of the physiological roles of
many DNA repair enzymes that can be performed in the
model systems by appropriate mutant analysis has provided
for convincing indications of the functions in vivo of several
repair activities in human cells. Thus, the major cytotoxic
lesion introduced in DNA on exposure of cells to simple
monofunctional alkylating agents, 3-alkyladenine, is removed
from the genome by exactly the same kind of excision
process involving a specific 3-alkyladenine-DNA glycosylase
in both E. coli and man. The data obtained with bacterial
mutants defective in only this form of excision-repair provide
conclusive proof for the strong cell killing effect of this
particular lesion in bacteria; it seems overwhelmingly likely
that the human repair enzyme with the identical biochemical
specificity as the E. coli activity in vitro also serves to remove
the same lesion in vivo, and that in the absence of repair, 3-
alkyladenine would be a strongly cytotoxic lesion in
mammalian cells exposed to alkylating agents. A final proof
of this notion would require access to mammalian cell lines
defective in the repair enzyme, but such mutant lines are not
presently available.
A strong advantage of work with the E. coli model system
is that the bacteria possess several inducible DNA repair
pathways. Human cells, on the other hand, exist in a more
stable environment and usually express analogous repair
activities constitutively at a relatively low level. Induced E.
coli cells, therefore, have served in several cases as an
abundant source of interesting proteins active in DNA
repair, and this has greatly facilitated the characterisation of
a number of novel repair functions. For example, the
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mutagenic and carcinogenic effect of simple alkylating agents
such as methylnitrosourea is primarily due to the generation
of 06-alkylguanine residues in DNA, which miscode during
replication and result in transition mutations (Loechler et al.,
1984; Zarbl et al., 1985). Bacterial and mammalian cells have
a limited ability to counteract such mutagenesis by repairing
06-alkylguanine residues prior to DNA replication. Attempts
to unravel the mechanism of this correction pathway by
direct work with mammalian systems were unsuccessful.
However, employing cell-free extracts from E. coli induced to
produce high levels of the activity, we could show that the
repair event was due to an unexpected transmethylation
reaction, with direct transfer of an alkyl group from the 06
position of guanine in DNA to a cysteine residue in a
protein (Olsson & Lindahl, 1980).
When this unique repair reaction had been elucidated, and
a specific and quantitative assay method developed for the
E. coli activity, it became a relatively simple task to
demonstrate the occurrence of lower levels of an analogous
enzyme activity in mammalian (including human) cell
extracts (Bogden et al., 1981; Harris et al., 1983; Pegg et al.,
1983).
The adaptive response to alkylating agents
The inducible repair pathway to counteract the effects of
alkylating agents, the adaptive response, was discovered ten
years ago at the Imperial Cancer Research Fund by Samson
and Cairns (1977). Exposure of E. coli to low, non-lethal
concentrations of alkylating agents caused increased
resistance to a subsequent challenge with a higher dose. This
work was extended to cell-free systems by the author in
collaboration with Peter Karran. We showed that the
response has two major components. Induced resistance to
cell killing is due to the induction of a DNA glycosylase
which releases from damaged DNA a number of base
derivatives that would otherwise block replication (Karran et
al., 1982a; Evensen & Seeberg, 1982; McCarthy et al., 1984).
Induced resistance to mutagenesis, on the other hand, can be
ascribed to the reversion of 06-alkylguanine to guanine by
the above-mentioned transmethylation reaction (Lindahl,
1982; Demple et al., 1985).
The adaptive response in E. coli is under the control of the
regulatory ada gene (Jeggo, 1979), which has been cloned
and sequenced in our laboratory (Sedgwick, 1983; Teo et al.,
1984; Demple et al., 1985; Nakabeppu et al., 1985). The
product of the ada gene unexpectedly turned out to be
identical with the alkyl transferase acting on 06-alkylguanine
(Teo et al., 1984). Thus, the protein has at least two
functions: it can act as a positive regulatory factor, and also
0.: The Macmillan Press Ltd., 1987 Br. J. Cancer (1987) 56, 91-9592 T. LINDAHL
as a DNA repair enzyme. Recent studies on the ada gene
product have shown that the protein exhibits a double-
domain structure. Two active fragments with different
functions can be physically separated after treatment of the
protein with low concentrations of trypsin (Sedgwick &
Lindahl, in preparation). The C-terminal half of the protein
serves to repair 06-alkylguanine residues in DNA, and
accounts for the antimutagenic effect. In this reaction, the
protein acts as its own alkyl group acceptor and is not
regenerated. Consequently, the repair response is easily
saturated in vivo by titration of the available protein
molecules by this suicide reaction (Robins & Cairns, 1979;
Lindahl et al., 1982). The N-terminal half of the protein can
also abstract an alkyl group from modified DNA to generate
an S-alkylcysteine residue, but this latter alkyl group is
derived from a minor (and apparently innocuous) DNA
lesion, one of the two stereoisomers of a phosphotriester
(McCarthy & Lindahl, 1985). The main purpose of the
second alkylation event appears to be conversion of the ada-
encoded protein to a transcriptional activator for the genes
involved in the inducible response to alkylating agents (Teo
et al., 1986; Nakabeppu & Sekiguchi, 1986). Methylating
agents such as methylnitrosoguanidine and methyl-
nitrosourea, which frequently produce phosphotriesters in
DNA, are the most effective inducers. The conformer of the
Ada protein with a methylcysteine residue in its N-terminal
half (the methyl group having been derived from a methyl-
phosphotriester in DNA) binds tightly to the specific
sequence d(AAANNAAAGCGCA) present in the promoter
regions of genes involved in the inducible response, at a site
immediately 'upstream' of the binding site for RNA
polymerase (Teo et al., 1986; Sedgwick, 1987). The DNA-
binding form of the ada-encoded protein presumably
facilitates transcription by a direct protein-protein
interaction with the RNA polymerase.
This inducible response to alkylating agents in bacteria is
of general interest in view of the fact that a novel type of
control of gene expression is involved, in which the
regulatory gene product requires post-translational covalent
modification before it can assume the role of an efficient
transcriptional activator. There is, however, no evidence for
the occurrence of a similar mechanism of inducible anti-
mutagenic DNA repair in eukaryotic cells. Treatment of
human cells in tissue culture with direct-acting alkylating
agents does not give rise to an increased resistance to the
same agents (Karran et al., 1982b; Frosina et al., 1984;
Yarosh et al., 1984). Moreover, it has been difficult to
obtain human tumour cell lines with markedly increased
resistance to simple alkylating agents (Teicher et al., 1986)
and the moderately improved resistance observed in certain
lines after prolonged exposure to alkylating agents is very
likely due to a mechanism different from that defined for
inducible bacteria.
The structure of the human repair protein, 06_
alkylguanine-DNA alkyltransferase, also supports the
concept of its non-inducibility: The human enzyme (24kDa)
is smaller than the E. coli ada gene product (39kDa) and
resembles the C-terminal domain (19 kDa) of the latter
protein. Thus, the human enzyme can repair 06-alkylguanine
in DNA by the same route as the bacterial Ada protein, but
the human activity cannot mimic the N-terminal domain of
the Ada protein to abstract alkyl groups from phospho-
triesters in DNA. Nevertheless, bacteria have been a valuable
model for higher cells, permitting a molecular definition of
the basic, constitutive repair processes for 06-alkylguanine
and other alkylation lesions in the DNA of human cells.
The Mer- (Mex-) phenotype
Whereas mammalian cell lines overproducing the 06_
alkylguanine-DNA alkyltransferase have not been observed,
Day et al. (1980), and Sklar and Strauss (1981) found that
20-30% of human tumour cell lines (designated either Mer-
or Mex-) appeared to be unable to remove 06-alkylguanine
from their DNA and were anomalously sensitive to killing
by simple alkylating agents. Direct enzyme assays with
cell-free extracts showed that the Mer- cells do not
express detectable amounts of 06-alkylguanine-DNA alkyl-
transferase in contrast to the ubiquitous presence of this
repair enzyme in normal cells and cell lines (Harris et al.,
1983; Yarosh et al., 1983). The prospect of the existence of a
sub-set of human tumours exhibiting anomalous sensitivity
to the cytotoxic effect of alkylating agents initially seemed a
very exciting development. However, studies of human
tumours per se indicated that extracts of tumour biopsies
always contain measurable amounts of transferase activity,
whereas cell lines established from such material are often of
the Mer- phenotype (Myrnes et al., 1983; Domoradzki et
al., 1984). A possible conclusion from this observation is
that the Mer- phenotype may arise when tumour cells are
grown in tissue culture, for example, because the culture
conditions might for unknown reasons confer a selective
growth advantage on rare Mer- cells occurring spon-
taneously in the tumour cell population.
The important question of the source of human Mer-
cells bears reinvestigation. Since solid tumours are always
infiltrated by normal cells such as fibroblasts and
lymphocytes, the occurrence of 06-alkylguanine-DNA alkyl-
transferase activity in cell-free extracts from tumour tissue
does not prove that the malignant cells themselves produce
the enzyme. Instead, the alterations of gene expression and
dedifferentiation processes taking place continuously in
tumours might in themselves lead to decreased or ceased
production of the particular DNA repair enzyme acting on
06-alkylguanine. If this were the case, a favourable situation
would exist for tumour therapy with alkylating agents. The
question whether certain human tumours contain a large
proportion of malignant cells of the Mer- phenotype could
be clarified by an immunological approach, but un-
fortunately specific antibodies to the human DNA alkyl-
transferase are not yet available. The considerable technical
problem holding up this line of research is that the repair
enzyme is only present in relatively small amounts in human
cells (about 50,000 molecules per cell of the 24kDa protein),
and in even smaller amounts in animal cells. Furthermore,
the enzyme appears to be very labile after partial puri-
fication, so a homogeneous (or even highly purified)
preparation has not yet been obtained from mammalian cells
(Pegg et al., 1983; Hall & Karran, 1986). For similar
reasons, the gene encoding the human transferase has not
been cloned, despite attempts by several research groups
using a variety of approaches.
Mer- cells are not only susceptible to agents such as
methylnitrosourea but also show greatly increased sensitivity
to the clinically used chloroethylnitrosoureas (Zlotogorski &
Erickson, 1983). This sensitivity arises because the
transferase can remove chloroethyl groups from the 06_
position of guanine in DNA, and 06-chloroethylguanine is
an obligatory chemical 'reaction intermediate in the
interstrand cross-linking of DNA by this group of anticancer
drugs (Robins et al., 1983; Brent, 1984; Ludlum et al., 1986).
It seems possible that improved methods for the analysis of
the Mer+ or Mer- state of human tumours might allow for
screening of biopsies and identification of a subset of
tumours that would be expected to respond particularly
favourably to treatment with chloroethylnitrosoureas,
because of their decreased repair capacity.
The molecular cloning and DNA sequencing of the E. coli
ada gene (Sedgwick, 1983; Demple et al., 1985; Nakebeppu
et al., 1985) made it possible to develop strategies for the
transfer of the gene to mammalian cells by shuttle vectors.
Several research groups have shown recently that the E. coli
ada gene can be expressed in mammalian cells, thereby
conveying to Mer- cells increased resistance to the cytotoxic
effect of alkylating agents (Samson et al., 1986; Brennand &
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These results demonstrate that 06-alkylguanine is not only a
strongly mutagenic residue, but also contributes significantly
to the cell-killing effect of alkylating agents on mammalian
cells.
A different way of modulating the response of human cell
lines to simple alkylating agents was demonstrated by
Karran, who showed that treatment of cells with high, but
non-toxic, concentrations of the free base 06-methylguanine
reversibly depletes the cells of their 06-alkylguanine-DNA
alkyltransferase activity (Karran, 1985; Karran & Williams,
1985). This method may be used for transient sensitisation of
tumour cell lines to chloroethylnitrosoureas (Yarosh, 1986;
Dolan et al., 1986; Day et al., 1987), but it is unclear at
present if this approach will be clinically useful in the
treatment of tumours with cross-linking nitrosoureas.
Repair ofoxygen-induced DNA damage
Potentially mutagenic or toxic DNA lesions arise
accidentally as an unwanted side effect of normal oxygen
metabolism. Ames (1983) has drawn attention to the large
number of environmental mutagens, including substances in
food, which might act through the formation of oxygen
radicals. Several repair enzymes that act on DNA exposed to
oxidising agents have been characterised in our laboratory:
these include (i) formamidopyrimidine-DNA glycosylase,
which catalyses the release of potentially cytotoxic purine
residues with an opened imidazole ring from y-ray-irradiated
DNA (Chetsanga & Lindahl, 1979; Boiteux & Laval, 1983;
Breimer, 1984); (ii) a separate DNA glycosylase which
releases urea (a remnant of thymine) and several other
derivatives with fragmented pyrimidine rings from oxidised
DNA (Breimer & Lindahl, 1980, 1984) - this enzyme is
identical with endonuclease III, which removes thymine
glycol from DNA (Demple & Linn, 1980); (iii) a Mg2 +
independent endonuclease for apurinic sites in DNA,
endonuclease IV (Ljungquist et al., 1976; Ljungquist, 1977;
Demple et al., 1986), which also removes 3-phosphoglycolate
residues from 3' termini of damaged DNA. Two distinct
DNA glycosylases with the specificities described are found
both in E. coli and in human cells (Breimer, 1983, 1984). The
enzyme that liberates thymine glycol and various substituted
urea derivatives from DNA is particularly interesting,
because this small, monomeric protein of 25kDa can remove
many different types of oxidised pyrimidine derivatives from
DNA, including several y-ray-induced products (Breimer &
Lindahl, 1985). We have speculated that this enzyme might
remove all pyrimidine derivatives that lack the 5,6 endocyclic
double bond, with a concomitant loss of the planar ring
structure necessary for effective hydrogen-bonding with the
complementary DNA chain, as well as the stacking
interactions with adjacent bases in the same chain. The
recognition of a structural distortion, rather than some
specific altered base product, provides a mechanism by
which a single DNA repair enzyme can remove a large series
of different base products, including many minor lesions,
from DNA exposed to ionising radiation. Another example
of this strategy is provided by the multi-subunit nuclease
encoded by the uvr genes, which recognises the major helical
distortion in DNA caused by several different bulky lesions
(van Houten et al., 1986).
The inducibility of repair of DNA alkylation damage in E.
coli has provided important new insights into the correction
mechanisms involved. Thus, the recent finding that bacteria
also possess two different types of inducible resistance to
oxidative DNA damage is of considerable interest. One
pathway is under the control of the oxyR gene and is
induced by exposure of cells to hydrogen peroxide; it
apparently confers increased resistance to the DNA damage
caused by ionising radiation as well as increasing
intracellular levels of several enzymes that directly detoxify
reactive oxygen species (Demple & Halbrook, 1983; Morgan
et al., 1986). Recently, endonuclease IV (and presumably
some other repair functions as well) has been found to be
induced in an oxyR-independent reaction by treatment of E.
coli with agents such as para-quinones, which primarily
generate superoxide radicals. Induction is much less efficient
with agents such as H202 or ionising radiation (Chan &
Weiss, 1987). In analogy with the previous results on E. coli
adapted to respond to alkylation damage, it might be
expected that E. coli cells induced to express large amounts
of DNA repair enzymes acting on oxygen damage will be
important in elucidating universally distributed mechanisms
for counteracting the effects of ionising radiation on cellular
genomes.
Human syndromes associated with defective DNA repair
The success of the microbial systems in elucidating the main
pathways of DNA repair has, to a large extent, depended on
the access to genetic analysis. In evaluating tentative
relationships between faulty DNA repair capacities in man
and possible increases in tumorigenesis, therefore, a few rare
inherited syndromes with the hallmarks of human repair-
defective mutants have been of critical importance, because
they are associated with a vastly increased cancer frequency
in the patients. These diseases include (i) xeroderma
pigmentosum, which exhibits a cellular phenotype similar to
that of E. coli uvr mutants; (ii) ataxia-telangiectasia, in which
patients are anomalously sensitive to ionising radiation -
cells representative of the syndrome seem unable to process
properly a damaged form of deoxyribose in DNA,
apparently leading to loss of a signal that inhibits DNA
synthesis on a damaged template (Shiloh et al., 1982; Painter
& Young, 1980); (iii) Fanconi's anaemia, in which cells are
anomalously sensitive to oxidative DNA damage and the
cross-linking agent mitomycin C; and (iv) Bloom's syndrome.
The latter is characterised by severely stunted growth and
sun-sensitivity in patients, and cells from such individuals
show a characteristic large increase in the frequency of
spontaneous sister chromatid exchange, as well as an
increased frequency of chromosome breakage (Chaganti et
al., 1974). In a survey of different DNA repair enzyme
activities in extracts of human lymphoid cell lines repre-
sentative of these various syndromes, we observed a decrease
in the level of one of the two DNA ligases of human cells,
ligase I, in Bloom's syndrome cells. DNA ligase I is the main
ligase active during DNA replication. Partial purification
and characterisation of the enzyme from normal cells and
Bloom's syndrome cells showed that the residual ligase I
from the latter source was anomalously heat-labile (Willis &
Lindahl, 1987). However, no decrease in the molecular
weight of the enzyme was apparent. These data suggest that
the molecular alteration in Bloom's syndrome is a missense
mutation in a transcribed and translated region of the gene
for DNA ligase I. Chan et al. (1987) have also observed a
ligase I with apparently unusual aggregation properties in
cells from Bloom's patients. The further definition of this
syndrome may now be pursued at a molecular level by
cloning and sequencing the gene for DNA ligase I from
normal and Bloom's syndrome cells, although human poly-
morphism may make this task a relatively time-consuming
effort. However, it may already be concluded that the
characteristic phenotype of this condition, with its observed
increased spontaneous DNA recombination frequencies, can
be adequately explained by a ligase defect (Willis & Lindahl,
1987). We have now investigated 6 different lines
representative of the syndrome, derived from different
individuals, and all contain a defective ligase I, whereas none
of 12 human control cell lines showed such an alteration
(Willis et al., in preparation).
Considerable efforts are made in many laboratories to
identify the altered genes in inherited human syndromes
with DNA repair defects by transfection of deficient cell
lines with cloned human DNA from normal cells. The94 T. LINDAHL
finding that Bloom's syndrome may be due to a specific
enzyme defect, as revealed by direct assays with cell-free
extracts, is representative of an alternative route of
investigation into the molecular origins of these human
diseases. This approach may now be extended to other
syndromes.
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